These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 14678737)
1. Nanotech approaches to drug delivery and imaging. Sahoo SK; Labhasetwar V Drug Discov Today; 2003 Dec; 8(24):1112-20. PubMed ID: 14678737 [TBL] [Abstract][Full Text] [Related]
2. Nanoparticles for improved therapeutics and imaging in cancer therapy. Chithrani DB Recent Pat Nanotechnol; 2010 Nov; 4(3):171-80. PubMed ID: 20618149 [TBL] [Abstract][Full Text] [Related]
3. The impact of nanobiotechnology on the development of new drug delivery systems. Kayser O; Lemke A; Hernández-Trejo N Curr Pharm Biotechnol; 2005 Feb; 6(1):3-5. PubMed ID: 15727551 [TBL] [Abstract][Full Text] [Related]
4. Nanotechnology and nanomedicine: going small means aiming big. Teli MK; Mutalik S; Rajanikant GK Curr Pharm Des; 2010 Jun; 16(16):1882-92. PubMed ID: 20222866 [TBL] [Abstract][Full Text] [Related]
5. Nanotechnology and site-targeted drug delivery. Petrak K J Biomater Sci Polym Ed; 2006; 17(11):1209-19. PubMed ID: 17176746 [TBL] [Abstract][Full Text] [Related]
6. Connecting drug delivery reality to smart materials design. Grainger DW Int J Pharm; 2013 Sep; 454(1):521-4. PubMed ID: 23624177 [TBL] [Abstract][Full Text] [Related]
8. Towards more effective advanced drug delivery systems. Crommelin DJ; Florence AT Int J Pharm; 2013 Sep; 454(1):496-511. PubMed ID: 23415662 [TBL] [Abstract][Full Text] [Related]
9. Potential impact of nanotechnology on the control of infectious diseases. Allaker RP; Ren G Trans R Soc Trop Med Hyg; 2008 Jan; 102(1):1-2. PubMed ID: 17706258 [TBL] [Abstract][Full Text] [Related]
10. Cancer nanotechnology: application of nanotechnology in cancer therapy. Misra R; Acharya S; Sahoo SK Drug Discov Today; 2010 Oct; 15(19-20):842-50. PubMed ID: 20727417 [TBL] [Abstract][Full Text] [Related]
12. Advanced drug delivery in motion. Mastrobattista E Int J Pharm; 2013 Sep; 454(1):517-20. PubMed ID: 23665006 [TBL] [Abstract][Full Text] [Related]
13. Active drug targeting: lessons learned and new things to consider. Al-Jamal KT Int J Pharm; 2013 Sep; 454(1):525-6. PubMed ID: 23558315 [TBL] [Abstract][Full Text] [Related]
14. Issues and concerns in nanotech product development and its commercialization. Kaur IP; Kakkar V; Deol PK; Yadav M; Singh M; Sharma I J Control Release; 2014 Nov; 193():51-62. PubMed ID: 24933600 [TBL] [Abstract][Full Text] [Related]
15. Clinical developments in drug delivery nanotechnology. Forrest ML; Kwon GS Adv Drug Deliv Rev; 2008 May; 60(8):861-2. PubMed ID: 18358557 [No Abstract] [Full Text] [Related]
16. [New intelligent and targetted drug delivery systems. Pharmaceutical and biomedical applications]. Peppas NA Ann Pharm Fr; 2006 Jul; 64(4):260-75. PubMed ID: 16902390 [TBL] [Abstract][Full Text] [Related]
17. In-silico simulations of advanced drug delivery systems: what will the future offer? Siepmann J Int J Pharm; 2013 Sep; 454(1):512-6. PubMed ID: 23867986 [TBL] [Abstract][Full Text] [Related]
18. Smart drug delivery systems: back to the future vs. clinical reality. Lammers T Int J Pharm; 2013 Sep; 454(1):527-9. PubMed ID: 23485339 [TBL] [Abstract][Full Text] [Related]
19. Recommendations of the National Heart, Lung, and Blood Institute Nanotechnology Working Group. Buxton DB; Lee SC; Wickline SA; Ferrari M; Circulation; 2003 Dec; 108(22):2737-42. PubMed ID: 14656908 [TBL] [Abstract][Full Text] [Related]
20. The dangers of generalization in nanotechnology. Florence AT Drug Discov Today; 2004 Jan; 9(2):60-1. PubMed ID: 15025067 [No Abstract] [Full Text] [Related] [Next] [New Search]